Seamus Mulligan - 04 Mar 2023 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role: Director
Signature: By: /s/Adam Guttmann, as attorney in fact For: Seamus Mulligan
Issuer symbol: JAZZ
Transactions as of: 04 Mar 2023
Net transactions value: +$266,085
Form type: 4
Filing time: 07 Mar 2023, 19:30:59 UTC
Previous filing: 09 Aug 2022
Next filing: 12 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JAZZ	Ordinary Shares	Options Exercise	$266,085	+4,500	+0.39%	$59.13	1,164,800	04 Mar 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	JAZZ	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-4,500	-100%	$0.000000^*	0	04 Mar 2023	Ordinary Shares	4,500	$59.13	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option was granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Option Plan and vested in 12 monthly installments over one year from the grant date, March 5, 2013.